ClinicalTrials.govpublic full text
Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy
pleural mesotheliomas, pleural mesothelioma, ivonescimab, bispecific antibody, anti-vegf, anti-pd-1, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871576
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.